Published December 6, 2007 | Version v1
Patent Open

COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS

  • 1. University of Chicago

Contributors

Patent applicant:

Description

The present invention relates to therapeutic combinations and methods of inhibiting the proliferation of cancerous cells, the abnormal growth of cells, and tumor cell growth using the combination of a hedgehog inhibitor with chemotherapy and/or radiation therapy. The present invention also relates to methods of enhancing the antiproliferative effect of chemotherapy and/or radiation therapy in a mammalian cancer patient undergoing either chemotherapy or radiation or a combination of radiation and chemotherapy by co-administering a therapeutically amount of a hedgehog inhibitor, concurrently or sequentially, with the chemotherapy and/or radiation therapy.

Files

US20070281040.pdf

Files (1.0 MB)

Name Size Download all
md5:dc1adc7f044af25240a32f8de0e8cf78
1.0 MB Preview Download

Additional details

Identifiers

Patent application number
US 57631005 A
Patent number
US 2007/0281040 A1
Other
oai:uchicago.tind.io:9116

Dates

Patent filed
2005-09-30

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Radiation and Cellular Oncology, Surgery, Ben May Department for Cancer Research